3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
93
Leukemia
70
Lymphoma
52
Leukemia, Myeloid, Acute
41
Burkitt Lymphoma
36
Myelodysplastic Syndromes
32
Lymphoma, Non-Hodgkin
27
Hodgkin Disease
27
Lymphoma, Mantle-Cell
24
Leukemia, Lymphocytic, Chronic, B-Cell
23
Recurrence
21
Lymphoma, Large B-Cell, Diffuse
21
Graft vs Host Disease
21
Lymphoma, Follicular
19
Congenital Abnormalities
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Multiple Myeloma
17
Leukemia, Myeloid, Accelerated Phase
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Myeloproliferative Disorders
15
Leukemia, Myelomonocytic, Chronic
15
Blast Crisis
15
Lymphoma, B-Cell, Marginal Zone
14
Leukemia, Myeloid, Chronic-Phase
13
Lymphoma, Large-Cell, Immunoblastic
12
Hematologic Neoplasms
12
Primary Myelofibrosis
11
Lymphoma, Large-Cell, Anaplastic
11
Breast Neoplasms
11
Neoplasms, Plasma Cell
10
Interventions
Gemcitabine
7
Cisplatin
5
Ramucirumab
3
Platinum
3
Paclitaxel
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Carboplatin
2
rucaparib
1
pegfilgrastim
1
pazopanib
1
eribulin
1
enzalutamide
1
enfortumab vedotin
1
dehydroftorafur
1
cabozantinib
1
avelumab
1
atezolizumab
1
aflibercept
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urethral Neoplasms
×
Methotrexate
×
Clear all
No trials found.